Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
News Source : Financial Post
News Summary
- New Study Provides Insight into the Bioavailability of Medical Cannabis Formulations for Therapeutic Treatment
- The study aimed to assess the pharmacokinetic parameters and relative bioavailability of two D9-tetrahydrocannabinol: cannabidiol (THC:CBD) formulations
- The findings may have significant implications for clinical populations using these formulations therapeutically
Tilray Medical is a leading provider of EUGMP certified and pharmaceuticalgrade medical cannabis products, having supplied over 20 countries with a comprehensive portfolio of THC and CBD products. [+4409 chars]